You're one step closer to unlocking our suite of comprehensive and robust tools.
Fill out the form so we can connect you to the right person.
OWC Pharmaceutical changes independent accounting firm
Architectural Shift In 5G Core Needed To Meet IoT Demands
US Consumer IoT Market: Key Penetration Rates Creeping Toward 30% in 2023
Thomas Cook Bankruptcy Case Study – What Were The Warning Signs?
US Broadband Only Homes Surge In Q3 Ahead Of Disney+ Launch
OWC Pharmaceutical Research Corp. decided not to re-engage its independent auditor M&K CPAS PLLC for the year ending Dec. 31.
The company did not have any disagreements with the outgoing accounting firm.
OWC Pharmaceutical engaged Fahn Kanne & Co. Grant Thornton Israel as the independent registered public accounting firm for the fiscal year ending Dec. 31.
The changes were effective Dec. 23.